SynthesisCurrent diabetes reports2026

Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes : Incretin Therapy in T2DM and PAD.

Larissa Araújo de Lucena et al.PubMed ↗Publisher ↗

No numbers read from the abstract.